BMO
GEHC icon

Beck Mack & Oliver’s GE HealthCare GEHC Stock Holding History

Beck Mack & Oliver’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,553
Closed -$206K – 191
2025
Q1 		$206K Buy
+2,553
New +$219K ﹤0.01% 172
2024
Q4 		– Sell
-2,553
Closed -$240K – 193
2024
Q3 		$240K Buy
+2,553
New +$214K ﹤0.01% 160
2024
Q2 		– Sell
-3,219
Closed -$293K – 179
2024
Q1 		$293K Sell
3,219
-8
-0.2% -$666 0.01% 148
2023
Q4 		$250K Hold
3,227
– – 0.01% 158
2023
Q3 		$220K Hold
3,227
– – 0.01% 154
2023
Q2 		$262K Hold
3,227
– – 0.01% 148
2023
Q1 		$265K Buy
+3,227
New +$230K 0.01% 152

Other funds holding GEHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Beck Mack & Oliver's GEHC Position: Q2 2025 in Review

Beck Mack & Oliver sold out of GE HealthCare (GEHC) in Q2 2025, closing a stake of 2,553 shares — an estimated $206K sold.

Beck Mack & Oliver first reported a position in GEHC in Q1 2023 and held it in 7 quarters. The position peaked at $293K in Q1 2024. 1,314 funds tracked by Wall St. Rank hold GEHC as of Q2 2025.

  • Beck Mack & Oliver reported no remaining GE HealthCare position as of Q2 2025 after selling out during the quarter.
  • Beck Mack & Oliver sold 2,553 GE HealthCare shares in Q2 2025, an estimated $206K.
  • Beck Mack & Oliver first reported a position in GE HealthCare in Q1 2023 and held it in 7 quarters.
  • Beck Mack & Oliver's GE HealthCare position peaked at $293K in Q1 2024.
  • 1,314 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2025.

Based on Beck Mack & Oliver's 13F filing for Q2 2025, filed 14 Aug 2025.